AtkinsRéalis stock reports 10 percent Q2 revenue growth from nuclear demand

Published on 10/05/2026 at 18:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AtkinsRéalis stock carries a CAD 20.2 billion backlog after its Q2 update. The shares traded at CAD 85.82 on October 5, with a CAD 14.0 billion market value.

ATRL, CA04764T1049, Illustration mit AI erstellt.

AtkinsRéalis stock (ISIN CA04764T1049) was trading at CAD 85.82 on the Toronto Stock Exchange on October 5, 2026 at 12:44 p.m. ET. The engineering and nuclear group reported 10 percent year-over-year revenue growth in the second quarter, while its backlog reached CAD 20.2 billion, according to AtkinsRéalis.

Q2 revenue reaches CAD 2.99 billion

The second-quarter revenue figure was CAD 2.99 billion, and net income attributable to shareholders reached CAD 96 million. Diluted GAAP EPS was CAD 0.59 for Q2 2026, while the company reported adjusted EPS of CAD 0.97 in its earnings-call transcript.

According to Benzinga, adjusted EBITDA increased 14 percent year over year to a quarterly record of CAD 293 million, while adjusted EPS increased 20 percent from CAD 0.81 in Q2 2025 to CAD 0.97 in Q2 2026.

Nuclear guidance rises to CAD 2.7 billion

Nuclear remains the central growth engine. Management raised its full-year 2026 nuclear revenue guidance to CAD 2.7 billion from CAD 2.5 billion, a CAD 200 million increase, while the Q2 nuclear segment delivered 18 percent organic revenue growth against Q2 2025.

The backlog adds scale to that outlook. Engineering services backlog reached a record CAD 13.4 billion as of June 30, 2026, while nuclear backlog stood at CAD 4.2 billion. The nuclear figure was down 25 percent year over year because work is progressing on the Pickering life-extension project, according to Benzinga.

Consensus target stays above the stock

MarketScreener lists a Buy consensus from 15 analysts and an average price target of CAD 115.40 for AtkinsRéalis. The target lies 34.5 percent above the CAD 85.82 price used for this comparison, although the market is also weighing project timing and execution in the nuclear backlog.

The company is pursuing international nuclear expansion alongside its engineering-services platform. Its Q2 call also highlighted a formal U.S. licensing process for CANDU technology and ongoing work to expand the business in North America.

AtkinsRéalis stock trades at CAD 85.82

AtkinsRéalis stock was trading at CAD 85.82 on the TSX on October 5, 2026 at 12:44 p.m. ET, down 0.68 percent from the prior close of CAD 86.41. The session range was CAD 85.12 to CAD 86.92, and the market capitalization was CAD 14.0 billion.